Trademark: 88064933
Word
HEIDELBERG PHARMA
Status Date
Tuesday, March 31, 2020
Registration Number
6021542
Registration Date
Tuesday, March 31, 2020
Filing Date
Friday, August 3, 2018
Published for Opposition
Tuesday, January 14, 2020
1 Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
5 Pharmaceutical preparations for the treatment of immuno oncological disorders, namely, cancer; pharmaceuticals for cancer therapy; chemico-pharmaceutical preparations for cancer therapies; pharmaceutical preparations and substances for use in the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer; pharmaceutical preparations for human use, namely, for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; clinical diagnostic reagents; diagnostic chemical reagents for medical use; anti-cancer drugs; compounds for treating cancer; anti-cancer preparations; anti-cancer preparations of chemical origin; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing
42 Pharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; laboratory services relating to the production of monoclonal antibodies
44 Pharmaceutical advice; pharmaceutical services, namely, providing pharmaceutical advice and consultation and dispensing drugs to patients with cancer; consultancy and medical information services relating to pharmaceutical products
The color(s) blue and light blue is/are claimed as a feature of the mark.
"PHARMA"
The mark consists of a blue circle within another light blue partial circular design, to the right of which appears the stylized word "Heidelberg" in blue letters. Appearing within the partial circular design, and under the word "Heidelberg" is the stylized word "PHARMA" in blue upper-case letters.
As to "HEIDELBERG PHARMA"
Jan 5, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 5, 2021
Teas Change Of Correspondence Received
Jan 5, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 5, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 5, 2021
Teas Change Of Owner Address Received
Mar 31, 2020
Registered-Principal Register
Jan 14, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 14, 2020
Published For Opposition
Dec 25, 2019
Notification Of Notice Of Publication E-Mailed
Dec 12, 2019
Approved For Pub - Principal Register
Dec 12, 2019
Examiner's Amendment Entered
Dec 12, 2019
Notification Of Examiners Amendment E-Mailed
Dec 12, 2019
Examiners Amendment E-Mailed
Dec 12, 2019
Examiners Amendment -Written
Nov 18, 2019
Teas/Email Correspondence Entered
Nov 18, 2019
Correspondence Received In Law Office
Nov 16, 2019
Assigned To Lie
Nov 11, 2019
Teas Response To Office Action Received
May 9, 2019
Notification Of Non-Final Action E-Mailed
May 9, 2019
Non-Final Action E-Mailed
May 9, 2019
Non-Final Action Written
Apr 26, 2019
Teas/Email Correspondence Entered
Apr 26, 2019
Correspondence Received In Law Office
Apr 26, 2019
Teas Response To Office Action Received
Nov 26, 2018
Notification Of Non-Final Action E-Mailed
Nov 26, 2018
Non-Final Action E-Mailed
Nov 26, 2018
Non-Final Action Written
Nov 21, 2018
Assigned To Examiner
Aug 10, 2018
Notice Of Design Search Code E-Mailed
Aug 9, 2018
New Application Office Supplied Data Entered In Tram
Aug 7, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
